Growing Prevalence of Respiratory Disorder Around the Globe is Escalating Growth of the Respiratory Trainer Market

Respiratory Trainer Market


 A respiratory trainer is a medical device that helps to prevent the spread of germs, allergies, and air borne diseases. It has many parts like a face mask, biological gauge, pressure garments, pressure band, nose clips, pressure equalizer, and air ventilation system. The Respiratory Trainer also helps to correct problems like sleep apnea, snoring, coughing, wheezing, and labored breathing. It is generally used in homes for preventing asthma attacks and reducing the chances of attack or disability. A respiratory trainer comprises two outer parts; the inner part consists of biological feedback device with electronic sensors and a mechanical valve; the outer part is a comfortable full-body cycling top. A respiratory Trainer is used to dilate airways, strengthening the diaphragm, enhancing lung expansion and increasing the residual volume of air breathed by the lungs. Residual volume refers to residual blood gas and residual blood volume (RV) of the lungs.

The growing prevalence of respiratory disorders around the globe is a prime factor driving the growth of the respiratory trainer market. According to the World Health Organization, about 65 million people suffer from chronic obstructive pulmonary disease (COPD), and 3 million die from it each year, making it the third leading cause of death worldwide. Technological advancement in the field of respiratory trainer coupled with the growing government expenditure for improving healthcare service is again projected to foster the growth of the respiratory trainer market. On the other hand, strict regulatory compliance procedures for the approval of the device is projected to restrict the market growth. 

North America is projected to exhibit significant growth over the forecast period and this is attributed to the advent of advanced medical devices and the high prevalence of asthma in the region. According to the Centers for Disease Control and Prevention (CDC), 1 in 13 people has asthma.1 More than 25 million Americans have asthma. This is 7.7 percent of adults and 8.4 percent of children. More than 11.4 million people with asthma, including more than 3 million children, report having had one or more asthma episodes or attacks in 2017. 

Key Developments:

    1. In October 2018, Aptar Pharma launched a new respiratory device at CPhI Worldwide. Aptar Pharma has also revealed a range of new connected drug delivery devices designed to increase dose adherence and improve patient outcomes; a portfolio of gamma-sterilized drug delivery components

    2. In May 2020, Smiths Medical announced that it has joined several of the world’s other ventilator manufacturers in the Ventilator Training Alliance (VTA) to support frontline medical providers' access to a centralized repository of ventilator training. 

Comments

Post a Comment

Popular posts from this blog

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vacci...
Read more

The Global Voice Prosthesis Devices Market Is Giving Voice to People with Voice Disabilities Caused Due To Surgery or Cancer and Key Players Are Trying To Make New Devices More Affordable

Image
  A voice prosthesis device is an electronic device, often made from silicon, which is used in combination with voice therapy for patients who have voice disorders and to aid those who suffer from vocal cord injuries. During a full vocal cordectomy, the vocal cords are completely removed and the airway and larynx are separated by a small incision. Voice prosthetics include full body units that can be worn as regular items and even become a part of the natural appearance of the body. Some patients choose to wear their prosthetics only during use while others prefer to wear them all the time. Some voice prosthetic devices are completely removable, while others have to be surgically installed or removed. As the number of people who need help with everyday communication increases, more are finding themselves in need of these devices. Market Dynamics                      ...
Read more